Webcast Alert for Biophan Technologies: Trilogy Capital's Emerging Growth Microcap Forum Announces the Addition of Two Keynote Speakers to Today's Webcast at 12 p.m. ET Richard Giest, Ph.D, and Paul Cohen to Speak ROCHESTER, N.Y., Nov. 21 /PRNewswire/ -- Biophan Technologies (BULLETIN BOARD: BIPH.OB) will webcast the following presentation: What: Biophan Technologies (OTC:BIPH.OB) (BULLETIN BOARD: BIPH.OB) will give a presentation at Informed Investors Emerging Growth/Microcap Stocks Forum When: November 21, 2003 @ 12:00 PM Eastern Time Where: http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339 How: Live over the Internet -- Simply log on to the web at the address above. Contact: AJ Cervantes, Trilogy Capital, , 800-330-1860 If you are unable to participate during the live webcast, the call will be available for replay at http://www.informedinvestors.com/iif_forums/forum.cfm?forumID=339. The keynote speakers today include Dr. Richard Geist, a well-known commentator, financial analyst and author of the recent national publication, Investment Therapy, available in major bookstores, as well as The Psychology of Investing, which was published in 2001. Dr. Geist appears regularly as an analyst for such programs as CNBC and CNN. In addition, Mr. Paul Cohen, the editor and publisher of the Cohen Independent Research Report will also speak on Microcap investing and the Microcap rationale. Biophan, based in Rochester, New York, develops and markets technology to enable biomedical devices both for interventional medicine, and implantable devices such as cardiac pacemakers and the other life sustaining medical devices, to be safe and compatible with magnetic resonance imaging (MRI) and other equipment using magnetic fields and radio waves. This MRI safe and compatible technology will be utilized in temporary and implantable pacemakers, implantable cardioverter-defibrillators and other medical equipment. For more information, please visit http://www.biophan.com/. Trilogy Capital Partners, Inc. is a proactive financial services company engaged in corporate communications, investor relations and strategic planning. Based on the simple concept that many well-run public companies are not realizing their full value in the marketplace, Trilogy has aggregated highly experienced executives into a formidable financial and marketing team. Our team utilizes proactive, technology-driven strategies and tools to drive public company visibility. For more information, please visit http://www.trilogy-capital.com/ or contact Racquel Rivera at . FORUM CONTACT: Janet Scharr, Informed Investors, 804-327-3424, . Web site: http://www.informedinvestors.com/ Certain statements included in this press release may constitute forward- looking statements. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of Biophan's MRI technologies; the approval of Biophan's patent applications; the successful implementation of Biophan's research and development programs; the acceptance by the market of Biophan's products; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in Biophan's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with Biophan's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and Biophan undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. DATASOURCE: Biophan Technologies CONTACT: AJ Cervantes of Trilogy Capital, or +1-800-330-1860 or Janet Scharr of Informed Investors, +1-804-327-3424, Web site: http://www.informedinvestors.com/ http://www.biophan.com/ http://www.trilogy-capital.com/

Copyright